Search results
Results from the WOW.Com Content Network
On a stand-alone basis, Globus Medical reaffirms its full year 2025 revenue guidance of $2.66 billion to $2.69 billion, and fully diluted non-GAAP earnings per share range between $3.40 to $3.50.
Globus Medical's results underscore a strong quarter, with effective execution of strategic initiatives, notably the full integration of the September 2023 NuVasive merger. Metric Q4 2024
Globus delivered an exceptional third quarter with sales of $626 million, growing 63% or $242 million. Non-GAAP EPS was a record $0.83, increasing 45% even with the 20% increase in diluted shares ...
Globus Medical (NYSE:GMED) has had a rough three months with its share price down 11%. But if you pay close attention...
Welcome to Globus Medical's second-quarter 2024 earnings call. [Operator instructions] I'll now turn the call over to Brian Kearns, senior vice president of business development and investor ...
Investor confidence continues to be high in Globus Medical (GMED), thanks to solid prospects.
For premium support please call: 800-290-4726 more ways to reach us
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.